← All stocks

Humacyte, Inc.

HUMA Net selling
CIK 0001818382 #3976 in the set updated 17 Sep 2026
Bought (120 mo)
$47.57M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$189.59M
$82.29K on a plan · $1.92M straight out of an exercise
Sold at will
$187.58M
80 of 90 sales
Net
−$142.02M
−$140.01M against sales at will

By person

16 insiders · 144 transactions
19.0×

Laura E. Niklason holds 19.0 times base salary in stock. $12.09M of shares against $633.61K in salary for 2025.

Salary from the company's own proxy. The shares are what Laura E. Niklason last reported holding, valued at $0.56, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Dougan Brady W
Director
$15.35M (8)
$75.54M (34)
−$60.19M
22,110,905
$12.43M
+2.7%
Niklason Laura E
President, CEO and Director
$15.35M (8)
$75.54M (34)
−$60.19M
21,506,516
$12.09M
+2.8%
Ayabudge LLC entity
10% owner
$15.23M (1)
$36.47M (11)
−$21.25M
8,191,140
$4.60M
Prichard Heather Ledbetter
Chief Operating Officer
$1.66M (6) scheduled
−$1.66M
0
$0.00
Binder Gordon M
Director
$1.13M (4)
+$1.13M
210,000
$118.02K
Sander Dale A.
CFO and Chief Corp. Dev. Off
$91.66K (3)
$304.27K (2) scheduled
−$212.61K
307,813
$172.99K
Constantino Michael T.
Director
$126.18K (8)
+$126.18K
43,950
$24.70K
Sebelius Kathleen
Director
$116.00K (2)
$28.00K (2) scheduled
+$88.00K
148,025
$83.19K
Scheessele William John
Chief Commercial Officer
$75.13K (3)
+$75.13K
22,018
$12.37K
Wallace Max N.
Director
$50.03K (2)
+$50.03K
60,540
$34.02K
Jones Keith Anthony
Director
$30.37K (3)
+$30.37K
50,000
$28.10K
Parikh Shamik J
Chief Medical Officer
$11.63K (1)
$41.15K (1) scheduled
−$29.52K
272,713
$153.26K
Green Charles Bruce
Director
$7.74K (1)
+$7.74K
8,400
$4.72K
Shukla Rajiv
Director
305,000
$171.41K
Tente William Edward
Chief Regulatory Officer
52,519
$29.52K
Lawson Jeffrey Harold
Chief Surgical Officer
7,877
$4.43K

No percentages here. This company's share count has moved by a factor of 2.2 over the window, from 125,859,496 to 277,798,105 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Green Charles Bruce
13 Sep 2024
Director
Exercised, kept
1,200
$4.09
$4.91K
Sebelius Kathleen
14 Jun 2024
Director
Exercised, kept
39,389
$2.56
$100.84K
Green Charles Bruce
20 May 2024
Director
Exercised, kept
600
$4.09
$2.45K
Green Charles Bruce
17 May 2024
Director
Exercised, kept
600
$4.09
$2.45K
Wallace Max N.
21 Nov 2023
Director
Exercised, kept
6,564
$1.19
$7.81K
Niklason Laura E
10 Oct 2023
President, CEO and Director
Exercised, kept
114,420
$1.19
$136.16K
Dougan Brady W
10 Oct 2023
Director
Exercised, kept indirect
114,420
$1.19
$136.16K
Niklason Laura E
1 Mar 2023
President, CEO and Director
Exercised, kept
100,000
$1.19
$119.00K
Dougan Brady W
1 Mar 2023
Director
Exercised, kept indirect
100,000
$1.19
$119.00K
Prichard Heather Ledbetter
12 Dec 2022
Chief Operating Officer
Exercised, kept
6,564
$1.15
$7.55K

What was left out

Form 4 filings counted 202
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 8
Sales at will 80
Transactions with no price 0
Shares from compensation/vesting 60,863,169
Sales filed before the plan box existed 23
History held since 23 Sep 2020